Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Farah Champsi


  • Large Shareholder at Allakos Inc. (ALLK), 2020-01-24
  • Large Shareholder at Sutro Biopharma Inc (STRO), 2018-10-01
  • Director at Kite Pharma Inc. (KITE), 2017-10-06
  • Other at Neothetics Inc. (NEOT), 2015-12-30
  • Large Shareholder at Zs Pharma Inc. (ZSPH), 2015-06-09
  • Large Shareholder at Atyr Pharma Inc (LIFE), 2015-05-15
  • Large Shareholder, Director at Trevena Inc (TRVN), 2014-12-10
  • Large Shareholder at Applied Genetic Technologies Corp (AGTC), 2014-11-19
  • Large Shareholder at Esperion Therapeutics Inc. (ESPR), 2014-10-22
  • Large Shareholder at Immune Design Corp. (IMDZ), 2014-07-31
  • Large Shareholder at Scynexis Inc (SCYX), 2014-05-09
  • Large Shareholder at Cara Therapeutics Inc. (CARA), 2014-02-05
  • Director at Chimerix Inc (CMRX), 2013-10-23
  • Director at Portola Pharmaceuticals Inc (PTLA), 2013-05-30
  • Large Shareholder at Aegerion Pharmaceuticals Inc. (AEGR), 2012-10-17
  • Other at Sunesis Pharmaceuticals Inc (SNSS), 2010-07-02
  • Large Shareholder at Anesiva Inc. (ANSV), 2010-01-08
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KITE $88.11 5,450 Director 0 2017-06-16 Filing
KITE $90.40 15,000 Director 63,664 2017-06-14 Filing
KITE $82.59 2,617 Director 4,962 2017-04-28 Filing
KITE $82.77 16,551 Director 7,579 2017-04-27 Filing
KITE $83.06 200 Director 24,130 2017-04-26 Filing